Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.02
HGR's Cash to Debt is ranked lower than
92% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 0.30 vs. HGR: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
HGR' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.06 Max: 0.62
Current: 0.02
0.01
0.62
Equity to Asset 0.46
HGR's Equity to Asset is ranked higher than
52% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HGR: 0.46 )
Ranked among companies with meaningful Equity to Asset only.
HGR' s 10-Year Equity to Asset Range
Min: 0.2  Med: 0.31 Max: 0.79
Current: 0.46
0.2
0.79
Interest Coverage 5.06
HGR's Interest Coverage is ranked lower than
60% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 6.81 vs. HGR: 5.06 )
Ranked among companies with meaningful Interest Coverage only.
HGR' s 10-Year Interest Coverage Range
Min: 0.43  Med: 2.39 Max: 13.53
Current: 5.06
0.43
13.53
F-Score: 4
Z-Score: 2.27
WACC vs ROIC
10.83%
10.75%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 11.02
HGR's Operating margin (%) is ranked higher than
62% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 7.35 vs. HGR: 11.02 )
Ranked among companies with meaningful Operating margin (%) only.
HGR' s 10-Year Operating margin (%) Range
Min: 2.59  Med: 11.05 Max: 15.73
Current: 11.02
2.59
15.73
Net-margin (%) 5.53
HGR's Net-margin (%) is ranked higher than
60% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 3.55 vs. HGR: 5.53 )
Ranked among companies with meaningful Net-margin (%) only.
HGR' s 10-Year Net-margin (%) Range
Min: -4.11  Med: 3.17 Max: 7.34
Current: 5.53
-4.11
7.34
ROE (%) 16.24
HGR's ROE (%) is ranked higher than
74% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 9.02 vs. HGR: 16.24 )
Ranked among companies with meaningful ROE (%) only.
HGR' s 10-Year ROE (%) Range
Min: -16.95  Med: 7.08 Max: 13.74
Current: 16.24
-16.95
13.74
ROA (%) 7.01
HGR's ROA (%) is ranked higher than
71% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 3.66 vs. HGR: 7.01 )
Ranked among companies with meaningful ROA (%) only.
HGR' s 10-Year ROA (%) Range
Min: -3.25  Med: 2.57 Max: 7.58
Current: 7.01
-3.25
7.58
ROC (Joel Greenblatt) (%) 46.29
HGR's ROC (Joel Greenblatt) (%) is ranked higher than
74% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 16.21 vs. HGR: 46.29 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HGR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.55  Med: 34.99 Max: 50.35
Current: 46.29
8.55
50.35
Revenue Growth (3Y)(%) 6.00
HGR's Revenue Growth (3Y)(%) is ranked lower than
58% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. HGR: 6.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HGR' s 10-Year Revenue Growth (3Y)(%) Range
Min: -7.3  Med: 4.55 Max: 38.3
Current: 6
-7.3
38.3
EBITDA Growth (3Y)(%) 22.30
HGR's EBITDA Growth (3Y)(%) is ranked higher than
83% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. HGR: 22.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HGR' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -24.7  Med: 9.65 Max: 51.5
Current: 22.3
-24.7
51.5
EPS Growth (3Y)(%) 41.20
HGR's EPS Growth (3Y)(%) is ranked higher than
88% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. HGR: 41.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HGR' s 10-Year EPS Growth (3Y)(%) Range
Min: -21.1  Med: 21.20 Max: 44.2
Current: 41.2
-21.1
44.2
» HGR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

HGR Guru Trades in Q3 2014

John Rogers 161,420 sh (New)
HOTCHKIS & WILEY 2,040,900 sh (+133.35%)
Paul Tudor Jones 17,600 sh (+109.52%)
John Keeley Sold Out
» More
Q4 2014

HGR Guru Trades in Q4 2014

HOTCHKIS & WILEY 3,416,494 sh (+67.40%)
John Rogers 253,785 sh (+57.22%)
HOTCHKIS & WILEY 3,416,494 sh (unchged)
Paul Tudor Jones 12,563 sh (-28.62%)
» More
Q1 2015

HGR Guru Trades in Q1 2015

HOTCHKIS & WILEY 3,735,078 sh (+9.32%)
HOTCHKIS & WILEY 3,663,594 sh (+7.23%)
Paul Tudor Jones Sold Out
John Rogers 211,755 sh (-16.56%)
» More
Q2 2015

HGR Guru Trades in Q2 2015

HOTCHKIS & WILEY 4,047,778 sh (+8.37%)
John Rogers 211,755 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with HGR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Hanger Inc

Hanger: A favorable aging demography trend
My approach to investment is to first identify a good business and then assess what is a reasonable valuation for the business. In general, I will come across some near-term risks, which cause my target companies to trade below my targeted valuation. For some of my targeted companies, I can anticipate whether the near-term issues can be resolved soon. For some others, I might not know whether the near-term issues will be resolved. However, the valuations sometimes have already reflected a good degree of negatives in the stocks. Today, Hanger (NYSE:HGR) is one of my targeted companies under the latter scenario. My analysis illustrates that HGR trades close to the bottom range of its historical valuation metrics, and HGR is a very solid company with good demography macro trend in its favor. For high-risk tolerant investors, I believe that HGR should be able to navigate through the current tough medical environment and the auditing issues. With patience and an eye to the long-term horizon, HGR should be able to reward its shareholders with more than 38% potential returns. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 9.68
HGR's P/E(ttm) is ranked higher than
93% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 27.50 vs. HGR: 9.68 )
Ranked among companies with meaningful P/E(ttm) only.
HGR' s 10-Year P/E(ttm) Range
Min: 9.51  Med: 16.52 Max: 43.7
Current: 9.68
9.51
43.7
PE(NRI) 9.90
HGR's PE(NRI) is ranked higher than
93% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 28.90 vs. HGR: 9.90 )
Ranked among companies with meaningful PE(NRI) only.
HGR' s 10-Year PE(NRI) Range
Min: 9.83  Med: 16.65 Max: 43.7
Current: 9.9
9.83
43.7
P/B 1.09
HGR's P/B is ranked higher than
87% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. HGR: 1.09 )
Ranked among companies with meaningful P/B only.
HGR' s 10-Year P/B Range
Min: 0.67  Med: 1.58 Max: 2.75
Current: 1.09
0.67
2.75
P/S 0.57
HGR's P/S is ranked higher than
79% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. HGR: 0.57 )
Ranked among companies with meaningful P/S only.
HGR' s 10-Year P/S Range
Min: 0.18  Med: 0.71 Max: 1.39
Current: 0.57
0.18
1.39
PFCF 12.89
HGR's PFCF is ranked higher than
74% of the 113 Companies
in the Global Medical Care industry.

( Industry Median: 22.16 vs. HGR: 12.89 )
Ranked among companies with meaningful PFCF only.
HGR' s 10-Year PFCF Range
Min: 3.44  Med: 16.33 Max: 38.85
Current: 12.89
3.44
38.85
POCF 7.15
HGR's POCF is ranked higher than
85% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.76 vs. HGR: 7.15 )
Ranked among companies with meaningful POCF only.
HGR' s 10-Year POCF Range
Min: 2.07  Med: 9.12 Max: 16.95
Current: 7.15
2.07
16.95
EV-to-EBIT 8.44
HGR's EV-to-EBIT is ranked higher than
91% of the 166 Companies
in the Global Medical Care industry.

( Industry Median: 20.01 vs. HGR: 8.44 )
Ranked among companies with meaningful EV-to-EBIT only.
HGR' s 10-Year EV-to-EBIT Range
Min: 8.1  Med: 10.30 Max: 38.4
Current: 8.44
8.1
38.4
PEG 1.10
HGR's PEG is ranked higher than
81% of the 68 Companies
in the Global Medical Care industry.

( Industry Median: 2.77 vs. HGR: 1.10 )
Ranked among companies with meaningful PEG only.
HGR' s 10-Year PEG Range
Min: 0.73  Med: 1.96 Max: 12.77
Current: 1.1
0.73
12.77
Shiller P/E 12.88
HGR's Shiller P/E is ranked higher than
87% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 30.14 vs. HGR: 12.88 )
Ranked among companies with meaningful Shiller P/E only.
HGR' s 10-Year Shiller P/E Range
Min: 12.67  Med: 34.09 Max: 123.5
Current: 12.88
12.67
123.5
Current Ratio 3.30
HGR's Current Ratio is ranked higher than
89% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. HGR: 3.30 )
Ranked among companies with meaningful Current Ratio only.
HGR' s 10-Year Current Ratio Range
Min: 1.98  Med: 3.06 Max: 4.27
Current: 3.3
1.98
4.27
Quick Ratio 2.08
HGR's Quick Ratio is ranked higher than
80% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. HGR: 2.08 )
Ranked among companies with meaningful Quick Ratio only.
HGR' s 10-Year Quick Ratio Range
Min: 1.37  Med: 2.08 Max: 2.63
Current: 2.08
1.37
2.63
Days Inventory 46.27
HGR's Days Inventory is ranked lower than
78% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 17.78 vs. HGR: 46.27 )
Ranked among companies with meaningful Days Inventory only.
HGR' s 10-Year Days Inventory Range
Min: 64.95  Med: 83.12 Max: 148.49
Current: 46.27
64.95
148.49
Days Sales Outstanding 63.92
HGR's Days Sales Outstanding is ranked lower than
77% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 46.02 vs. HGR: 63.92 )
Ranked among companies with meaningful Days Sales Outstanding only.
HGR' s 10-Year Days Sales Outstanding Range
Min: 50.65  Med: 70.08 Max: 132.78
Current: 63.92
50.65
132.78

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.70
HGR's Price/Projected FCF is ranked higher than
91% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.53 vs. HGR: 0.70 )
Ranked among companies with meaningful Price/Projected FCF only.
HGR' s 10-Year Price/Projected FCF Range
Min: 0.33  Med: 0.84 Max: 1.58
Current: 0.7
0.33
1.58
Price/Median PS Value 0.83
HGR's Price/Median PS Value is ranked higher than
80% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. HGR: 0.83 )
Ranked among companies with meaningful Price/Median PS Value only.
HGR' s 10-Year Price/Median PS Value Range
Min: 0.07  Med: 0.81 Max: 3.12
Current: 0.83
0.07
3.12
Price/Peter Lynch Fair Value 0.71
HGR's Price/Peter Lynch Fair Value is ranked higher than
90% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. HGR: 0.71 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HGR' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.49  Med: 1.37 Max: 4.63
Current: 0.71
0.49
4.63
Earnings Yield (Greenblatt) (%) 11.85
HGR's Earnings Yield (Greenblatt) (%) is ranked higher than
93% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. HGR: 11.85 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HGR' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 2.6  Med: 9.70 Max: 12.4
Current: 11.85
2.6
12.4
Forward Rate of Return (Yacktman) (%) 20.43
HGR's Forward Rate of Return (Yacktman) (%) is ranked higher than
75% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 11.15 vs. HGR: 20.43 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HGR' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -0.5  Med: 11.10 Max: 26.1
Current: 20.43
-0.5
26.1

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:HO8.Germany,
Hanger Inc was incorporated on March 3, 1988. The Company is a provider of services and products that enhance human physical capabilities. It provides orthotic and prosthetic patient-care services, distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to the broader post acute market. It has two operating segments: Patient Care and Products & Services. Patient Care segment is comprised of Hanger Clinic, Cares, Dosteon, other related O&P businesses and its contracting network management business. Through this segment, it is the owner and operator of orthotic and prosthetic patient care clinics in the United States and manages an O&P provider network of approximately 1,150 clinics that coordinates all aspects of O&P patient care for insurance companies. It operates in excess of 740 O&P patient care clinics located in 45 states and the District of Columbia. Products & Services segment is comprised of its distribution business, one of the largest distributors of O&P products in the United States, and its rehabilitative solutions business. Its distribution facilities in California, Florida, Georgia, Illinois, Pennsylvania and Texas allow it to deliver products to the vast majority of its distribution customers in the United States within two business days. Its rehabilitative solutions business develops specialized rehabilitation technologies and is a leading provider of evidence-based clinical programs for post-acute rehabilitation, serving more than 4,200 long-term care facilities and other sub-acute rehabilitation providers throughout the United States. This segment also develops neuromuscular technologies through independent research. The Patient Care segment competes with numerous small independent O&P providers for referrals from physicians, therapists, employers, HMOs, PPOs, hospitals, rehabilitation centers, out-patient clinics and insurance companies on both a local and regional basis. It competes with other patient care service providers, including device manufacturers that have independent sales forces, on the basis of quality and timeliness of patient care, location of patient care clinics and pricing for services. The Products & Services segment competes with other distributors, manufactures who sell their products directly, and providers of equipment and services on a regional and national basis that have similar sales forces and products. Some of its distributor competitors are also dedicated to the O&P industry, but many others are large medical product distributors who also distribute O&P products, particularly orthotic products. The Company is subject to a variety of federal, state and local governmental regulations.
» More Articles for HGR

Headlines

Articles On GuruFocus.com
John Rogers Has Busy Third Quarter Nov 12 2014 
Hanger: A favorable aging demography trend Sep 08 2014 
Hanger Orthopedic Group Inc. Reports Operating Results (10-K) Mar 11 2011 
Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 26,000 Sh Feb 28 2011 
John Keeley Buys CAR, HGR, NCR, DAN, SKS, FELE, NWBI, FII, MF, HHC Feb 09 2011 
Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 30,000 Sh Nov 22 2010 
Hanger Orthopedic Group Inc. (HGR) President and CEO Thomas F Kirk sells 10,030 Shares Nov 18 2010 
Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 1,525 Sha Nov 18 2010 
Hanger Orthopedic Group Inc. (HGR) President and CEO Thomas F Kirk sells 11,458 Shares Aug 13 2010 
Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 3,348 Sha Aug 13 2010 

More From Other Websites
Director’s Share Dealings Aug 28 2015
Publication of Circular Aug 26 2015
Proposed transfer of listing category on the Official List from premium to standard Aug 26 2015
Interim results for the six months ended June 30, 2015 Aug 26 2015
Anglo Pacific Interim Results 2015 webcast Aug 24 2015
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Hanger, Inc. Aug 21 2015
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Hanger, Inc. -... Aug 20 2015
Harwood Feffer LLP Announces Investigation of Hanger Inc. Aug 20 2015
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Hanger, Inc.... Aug 20 2015
Federman & Sherwood Investigates Hanger, Inc. for Possible Violations of Federal Securities Laws Aug 19 2015
HANGER, INC. Files SEC form 8-K, Other Events Aug 17 2015
HANGER, INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 14 2015
Narrabri production guidance FY2016 Aug 13 2015
Notice of Results: Interim Results for 2015 Aug 05 2015
Boston media outlets feature Hanger Clinic patient Mike Benning and new microprocessor-controlled... Jul 28 2015
Hanger Clinic patient first woman in U.S. to be fit with i-limb quantum hand Jul 27 2015
Hanger announces new Chief Information Officer Scott Ranson Jul 20 2015
HANGER, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 20 2015
Hanger announces new Chief Information Officer Scott Ranson Jul 20 2015
Royalty Update: Narrabri Jul 17 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK